Adenocor

Country: New Zealand

Language: English

Source: Medsafe (Medicines Safety Authority)

Active ingredient:

Adenosine 3 mg/mL (candida utilis lysed to get RNA,then hydrolysed to adenosine);  

Available from:

Pharmacy Retailing (NZ) Ltd t/a Healthcare Logistics

INN (International Name):

Adenosine 3 mg/mL (candida utilis lysed to get RNA,then hydrolysed to adenosine)

Dosage:

6 mg/2mL

Pharmaceutical form:

Solution for injection

Composition:

Active: Adenosine 3 mg/mL (candida utilis lysed to get RNA,then hydrolysed to adenosine)   Excipient: Sodium chloride Water for injection

Units in package:

Vial, glass, single dose, 6 x 2ml, 12 mL

Class:

Prescription

Prescription type:

Prescription

Manufactured by:

Farmak a.s.

Therapeutic indications:

Adenocor is indicated for rapid conversion to a normal sinus rhythm of paroxysmal supraventricular tachycardias, including those associated with accessory bypass tracts (Wolff-Parkinson-White syndrome), and as an aid to diagnosis of broad or narrow QRS complex supraventricular tachycardias, and in sensitisation of intracavity electrophysiological investigations.

Product summary:

Package - Contents - Shelf Life: Vial, glass, single dose, 6 x 2ml - 12 mL - 36 months from date of manufacture stored at or below 25°C

Authorization date:

1993-09-22

Patient Information leaflet

Adenocor
®
1
ADENOCOR®
CONSUMER MEDICINE INFORMATION (CMI) SUMMARY
The full CMI on the next page has more details. If you are worried
about using this medicine, speak to your doctor or pharmacist.
1.
WHY AM I USING ADENOCOR?
Adenocor contains the active ingredient adenosine. Adenocor is used as
an aid to doctors, to understand how your heart is
working. Adenocor is a type of medicine used to treat a condition
where the heart beats too rapidly.
For more information, see Section 1. Why am I using Adenocor?
in the full CMI.
2.
WHAT SHOULD I KNOW BEFORE I USE ADENOCOR?
Do not use if you have ever had an allergic reaction to Adenocor or
any of the ingredients listed at the end of the CMI.
TALK TO YOUR DOCTOR IF YOU HAVE ANY OTHER MEDICAL CONDITIONS, TAKE ANY
OTHER MEDICINES, OR ARE PREGNANT OR PLAN TO BECOME
PREGNANT OR ARE BREASTFEEDING.
For more information, see Section 2. What should I know before I use
Adenocor?
in the full CMI.
3.
WHAT IF I AM TAKING OTHER MEDICINES?
Some medicines may interfere with Adenocor and affect how it works.
A list of these medicines is in Section 3. What if I am taking other
medicines?
in the full CMI.
4.
HOW DO I USE ADENOCOR?
•
Adenocor will only be given to you in hospital.
•
Adenocor will be given to you as a rapid injection over a couple of
seconds.
More instructions can be found in Section 4. How do I use Adenocor?
in the full CMI.
5.
WHAT SHOULD I KNOW WHILE USING ADENOCOR?
THINGS YOU
SHOULD DO
•
Remind any doctor, dentist or pharmacist you visit that you have been
given Adenocor.
THINGS YOU
SHOULD NOT DO
•
Do not eat or drink food or drinks containing caffeine (e.g. coffee,
tea, chocolate or cola) for at least
12 hours before you receive your injection.
LOOKING AFTER
YOUR MEDICINE
•
Adenocor is stored in the pharmacy or on the ward.
•
Adenocor is kept in a cool, dry place where the temperature stays
below 25°C.
•
Not to be refrigerated.
For more information, see Section 5. What should I know while using
Adenocor? in the full CMI.
6.
ARE THERE ANY SIDE EFFECTS?
T

Summary of Product characteristics

New Zealand Data Sheet
Adenocor - adenosine
Property of the Sanofi group - strictly confidential
adenocor-ccdsv9-dsv7-02sep22
Page 1
DATA SHEET
1
ADENOCOR 6 MG/2 ML SOLUTION FOR INTRAVENOUS
INFUSION
ADENOCOR 6 mg/2 mL solution for intravenous infusion.
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each vial contains 6 mg of adenosine per 2 mL.
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Solution for intravenous infusion
Clear, colourless solution
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
THERAPEUTIC INDICATIONS
Rapid conversion to a normal sinus rhythm of paroxysmal
supraventricular tachycardias,
including those associated with accessory bypass tracts
(Wolff-Parkinson-White syndrome).
DIAGNOSTIC INDICATIONS
Aid to diagnosis of broad or narrow QRS complex supraventricular
tachycardias. Although
ADENOCOR is not effective in converting atrial flutter, atrial
fibrillation or ventricular
tachycardia to sinus rhythm, the slowing of AV conduction helps
diagnosis of atrial activity.
Sensitisation of intracavity electrophysiological investigations.
New Zealand Data Sheet
Adenocor - adenosine
Property of the Sanofi group - strictly confidential
adenocor-ccdsv9-dsv7-02sep22
Page 2
4.2
DOSE AND METHOD OF ADMINISTRATION
METHOD OF ADMINISTRATION
ADENOCOR should be used only in hospitals, with monitoring and
cardiorespiratory
resuscitation equipment available for immediate use if necessary. It
should be administered by
rapid IV bolus injection according to the ascending dosage schedule
below. To be certain the
solution reaches the systemic circulation, it should be administered
either directly into a vein or
into an IV line. If administered via an IV line it should be injected
as proximally as possible, and
followed by a rapid saline flush.
ADENOCOR should only be used when facilities exist for cardiac
monitoring. Patients who
develop high-level AV block at a particular dose should not be given
further dosage increments.
THERAPEUTIC DOSE
_ADULTS _
Initial dose: 3 mg given as a rapid intravenous